No abstract available.
Adult* ; Growth Hormone* ; Humans

No abstract available.
Cardiovascular Diseases* ; Growth Hormone*

No abstract available.
Insulin-Like Growth Factor I*

The safe clinical practice of growth hormone(GH) replacement requires judgement of the overall GH status, however, there is no biological marker for this in adults. In addition, diverse actions of GH in healthy individuals render the assessment of optimal GH replacement difficult. As in other fields of clinical practice, strategies and protocols vary between centers, however, most physicians experienced in pituitary diseases agree that GH replacement should begin at low doses, and increased to the final maintenance dose. The adequacy replacement is best determined by combination of clinical response and serum IGF-I, level avoiding supraphysiological levels of this GH-dependent peptide. Actually, GH can reduce body fat and restore muscles, bones, and quality of life. Appropriate using of GH will elicit antiaging effects.
Adipose Tissue ; Adult ; Biomarkers ; Growth Hormone* ; Humans ; Insulin-Like Growth Factor I ; Muscles ; Osteoporosis ; Pituitary Diseases ; Quality of Life

No abstract available.
Growth Hormone

No abstract available.
Growth Hormone*

No abstract available.
Brassica* ; Ear*

The echocardiographic study was performed to 13 cases with Hypertrophic Cardiomyopathy and 105 normal persons between Nov. 1980 and Feb. 1982 in Heart center, Paik Hospital, In-Je Medical College, Busan, Korea. The left ventricular functions in the Hypertrophic cardiomyopathy were compared with those in the normal. The results were followings: 1. There were 10 male and 3 female of 13 cases with Hypertrophic Cardiomyopathy, whose ages were above 20 years old. 2. LVDeD 4.29+/-0.60cm, LVSeD 2.85+/-0.66cm, LVDeV 82.06+/-24.66ml and LVSeV 26.91+/-9.21ml in the Hypertrophic Cardiomyopathy were significantly changed with those in the normal. 3. E.F. 68.63+/-10.46% and F.S. 34.32+/-6.43% in the Hypertrophic Cardiomopathy were significantly increased with those in the normal. 4. VSTh 1.66+/-0.37cm, LVPWTh 1.04+/-0.29cm in the Hypertrophic Cardiomyopathy were significantly increased with those in the normal.
Busan ; Cardiomyopathy, Hypertrophic* ; Echocardiography* ; Female ; Heart ; Humans ; Korea ; Male ; Ventricular Function, Left ; Young Adult

No abstract available.
Pneumocephalus*

No abstract available.
Korea*